Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice

Anaplastic plasmacytomas (APCTs) from NFS.V+ congenic mice and pristane‐induced plasmacytic PCTs from BALB/c mice were previously shown to be histologically and molecularly distinct subsets of plasma cell neoplasms (PCNs). Here we extended these comparisons, contrasting primary APCTs and PCTs by gene expression profiling in relation to the expression profiles of normal naïve, germinal centre, and memory B cells and plasma cells. We also sequenced immunoglobulin genes from APCT and APCT‐derived cell lines and defined surface phenotypes and chromosomal features of the cell lines by flow cytometry and by spectral karyotyping and fluorescence in situ hybridization. The results indicate that APCTs share many features with normal memory cells and the plasma cell‐related neoplasms (PLs) of FASL‐deficient mice, suggesting that APCTs and PLs are related and that both derive from memory B cells. Published in 2010 by John Wiley & Sons, Ltd.

[1]  Yasuhiro Imamura,et al.  BLNK Binds Active H-Ras to Promote B Cell Receptor-mediated Capping and ERK Activation* , 2009, Journal of Biological Chemistry.

[2]  M. Nussenzweig,et al.  AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations , 2008, Cell.

[3]  D. Roopenian,et al.  NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas. , 2008, Cancer research.

[4]  F. Alt,et al.  AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development , 2008, The Journal of experimental medicine.

[5]  O. Ohara,et al.  Discriminating gene expression profiles of memory B cell subpopulations , 2008, The Journal of experimental medicine.

[6]  A. Plebani,et al.  Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF1 , 2008, The Journal of Immunology.

[7]  C. Picard,et al.  Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+IgD+CD27+ B cell repertoire in infants , 2008, The Journal of experimental medicine.

[8]  P. L. Bergsagel,et al.  AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. , 2008, Cancer cell.

[9]  M. Gertz New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression , 2008, Leukemia & lymphoma.

[10]  T. Ried,et al.  AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements , 2007, The Journal of experimental medicine.

[11]  I. Weissman,et al.  Transcriptional Profiling of Antigen-Dependent Murine B Cell Differentiation and Memory Formation1 , 2007, The Journal of Immunology.

[12]  E. Pinaud,et al.  The 3′ IgH Locus Control Region Is Sufficient to Deregulate a c-myc Transgene and Promote Mature B Cell Malignancies with a Predominant Burkitt-Like Phenotype1 , 2007, The Journal of Immunology.

[13]  M. Tomayko,et al.  New markers for murine memory B cells that define mutated and unmutated subsets , 2007, The Journal of experimental medicine.

[14]  M. Hallek,et al.  Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases , 2007, Oncogene.

[15]  S. Tangye,et al.  Human IgM+CD27+ B Cells: Memory B Cells or “Memory” B Cells?1 , 2007, The Journal of Immunology.

[16]  I. Henderson,et al.  Salmonella Induces a Switched Antibody Response without Germinal Centers That Impedes the Extracellular Spread of Infection1 , 2007, The Journal of Immunology.

[17]  S. Janz,et al.  A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma. , 2007, Cancer research.

[18]  Chen-feng Qi,et al.  Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. , 2007, Cancer research.

[19]  B. Barlogie,et al.  IgM-expressing Waldenstrom's macroglobulinemia tumor cells reveal a potential for isotype switch events in vivo , 2007, Leukemia.

[20]  H. Woo,et al.  Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia , 2007, BMC Genomics.

[21]  S. Janz,et al.  Myc translocations in B cell and plasma cell neoplasms. , 2006, DNA repair.

[22]  H. Avraham,et al.  Identification of the nonreceptor tyrosine kinase MATK/CHK as an essential regulator of immune cells using Matk/CHK-deficient mice. , 2006, Blood.

[23]  Joshy Jacob,et al.  Identification of Memory B Cells Using a Novel Transgenic Mouse Model1 , 2006, The Journal of Immunology.

[24]  M. Wasik,et al.  Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma , 2006, Oncogene.

[25]  S. Nutt,et al.  Early appearance of germinal center–derived memory B cells and plasma cells in blood after primary immunization , 2005, The Journal of experimental medicine.

[26]  T. Ried,et al.  Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. , 2005, Cancer research.

[27]  L. McHeyzer-Williams,et al.  Antigen-specific memory B cell development. , 2005, Annual review of immunology.

[28]  M. Shin,et al.  Evidence for Selective Transformation of Autoreactive Immature Plasma Cells in Mice Deficient in Fasl , 2004, The Journal of experimental medicine.

[29]  M. Nussenzweig,et al.  AID Is Required for c-myc/IgH Chromosome Translocations In Vivo , 2004, Cell.

[30]  S. Janz,et al.  Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice. , 2004, The Journal of clinical investigation.

[31]  R. Mulligan,et al.  Critical Role for Hematopoietic Cell Kinase (Hck)-mediated Phosphorylation of Gab1 and Gab2 Docking Proteins in Interleukin 6-induced Proliferation and Survival of Multiple Myeloma Cells* , 2004, Journal of Biological Chemistry.

[32]  M. Potter Neoplastic development in plasma cells , 2003, Immunological reviews.

[33]  K. Toellner,et al.  Extrafollicular antibody responses , 2003, Immunological reviews.

[34]  Andrea Califano,et al.  Transcriptional analysis of the B cell germinal center reaction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Hatano,et al.  Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells. , 2002, Immunity.

[36]  P. L. Bergsagel,et al.  Chromosome translocations in multiple myeloma , 2001, Oncogene.

[37]  T. Ried,et al.  Chromosomes 1 and 5 harbor plasmacytoma progressor genes in mice , 2000, Genes, chromosomes & cancer.

[38]  A. W. Harris,et al.  Atlas Of Mouse Hematopathology , 2000 .

[39]  H. Morse,et al.  Accelerated Appearance of Multiple B Cell Lymphoma Types in NFS/N Mice Congenic for Ecotropic Murine Leukemia Viruses , 2000, Laboratory Investigation.

[40]  R. Scheuermann,et al.  Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor. , 2000, Advances in immunology.

[41]  G. Dighiero,et al.  Restricted Immunoglobulin Variable Region (Ig V) Gene Expression Accompanies Secondary Rearrangements of Light Chain Ig V Genes in Mouse Plasmacytomas , 1999, The Journal of experimental medicine.

[42]  R. Bataille,et al.  V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events. , 1999, Blood.

[43]  M. Potter,et al.  BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis. , 1999, International immunology.

[44]  Andrew C. Chan,et al.  BLNK Required for Coupling Syk to PLCγ2 and Rac1-JNK in B Cells , 1999 .

[45]  V. Kindler,et al.  Quiescent memory B cells in human peripheral blood co‐express bcl‐2 and bcl‐xL anti‐apoptotic proteins at high levels , 1998, European journal of immunology.

[46]  T. Giese,et al.  Spontaneous Development of Plasmacytoid Tumors in Mice with Defective Fas–Fas Ligand Interactions , 1998, The Journal of experimental medicine.

[47]  A. Kovalchuk,et al.  Deletional remodeling of c-myc-deregulating chromosomal translocations , 1997, Oncogene.

[48]  S. Rudikoff,et al.  Characterization of C57BL/6 plasmacytomas lacking a c‐myc translocation , 1997, International journal of cancer.

[49]  K. Rajewsky,et al.  Evidence for a large compartment of IgM-expressing memory B cells in humans. , 1997, Blood.

[50]  J. Shaughnessy,et al.  Detection of recombinations between c-myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  T. Hirano,et al.  [Interleukin-6 and its receptor]. , 1991, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[52]  A. W. Harris,et al.  Lymphoid tumorigenesis by v-abl and BCR-v-abl in transgenic mice. , 1990, Current topics in microbiology and immunology.

[53]  J. Croese,et al.  Animal model of human disease. Multiple myeloma. , 1988, The American journal of pathology.

[54]  S. Klinken,et al.  Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. , 1988, Journal of immunology.

[55]  W. O'Fallon,et al.  Multiple myeloma: significance of plasmablastic subtype in morphological classification. , 1985, Blood.

[56]  C. Taylor,et al.  Emergence of B-immunoblastic sarcoma in patients with multiple myeloma: a clinicopathologic study of 10 cases. , 1982, Blood.